ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF
- Видео
- О видео
- Скачать
- Поделиться
ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF
Dr Harriette Van Spall (McMaster University, Hamilton, CA) and Dr Deepak L Bhatt (Brigham and Women's Hospital, Boston, MA, US) discussed the latest data on the benefits of SGLT2/1 inhibition across the full spectrum of ejection fraction, including HFpEF. Recorded remotely from Boston and Hamilton, 2021. Editor: Mirjam Boros
568 | 3 год. назад | 4 - 0
Dr Harriette Van Spall (McMaster University, Hamilton, CA) and Dr Deepak L Bhatt (Brigham and Women's Hospital, Boston, MA, US) discussed the latest data on the benefits of SGLT2/1 inhibition across the full spectrum of ejection fraction, including HFpEF.
Recorded remotely from Boston and Hamilton, 2021.
Editor: Mirjam Boros
Чтобы скачать видео "ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF" передвинте ползунок вправо
- Комментарии
Комментарии ФБ